Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
9.00
-0.31 (-3.33%)
At close: Jul 3, 2025, 1:00 PM
9.01
+0.01 (0.11%)
After-hours: Jul 3, 2025, 4:59 PM EDT
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $14.39 million as of July 3, 2025. Its market cap has decreased by -12.77% in one year.
Market Cap
14.39M
Enterprise Value
16.01M
1-Year Change
-12.77%
Ranking
Category
Stock Price
$9.00
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $14.39M, a decrease of -93.75%. That is a compound annual growth rate of -41.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 14.39M | 6.47% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.11B |